Omnicell

JANUARY 10, 2023

Our anesthesia department recently formed a new diversion-prevention team within the hospital. The Chief of Anesthesia is now aware of flaws in documentation and has an awareness of open transactions through enhanced data visibility.

Omnicell 52

Omnicell Medication Dispensing CPhT Documentation 52

Omnicell

JANUARY 10, 2023

Patrick Guffey, MD, Chief Medical Information Officer at Children's Hospital Colorado and Anesthesiologist at Children's Hospital Colorado, on the latest edition of the Future of Pharmacy Podcast to discuss achieving the delicate balance of medication management in the operating room.

Controlled Substances 52

Controlled Substances Omnicell Medication Dispensing Documentation 52

indispensable health

AUGUST 18, 2023

Technology offers a lifeline by automating documentation, report generation, and data entry: A. Voice Recognition Technology: Dictating notes through voice recognition software expedites documentation, freeing nurses from typing and ensuring accurate records.

Data Entry 52

Data Entry Communication Patient Care Medication Dispensing 52

Omnicell

JANUARY 10, 2023

When you consider that the OR accounts for 40% of hospital expenses and 70% of revenue , why wouldn’t you want optimal medication management in such a critical area? Omnicell has continued to refine medication workflow with the XT Anesthesia Workstation™ , and new functionality helps both parties accomplish this goal.

Controlled Substances 52

Controlled Substances Omnicell Medication Dispensing Documentation 52

The Checkup by Singlecare

MARCH 16, 2023

A number of factors have fueled the transformation of the pharmacy tech role, says Dr. Staiger, including a growing demand for healthcare services, the need to improve operational efficiencies, and the increasing complexity of medications, dispensing requirements, and billings. Responsibilities vary, but may include: 1. Dr. Staiger.

Data Entry 52

Data Entry Long-Term Care Facilities Insurance Immunization 52

The FDA Law Blog

OCTOBER 17, 2023

Background The Breakthrough Devices Program, established under section 515B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is a voluntary program for certain medical devices and device-led combination products. By Philip Won & Lisa M. Wysa, see here ) and addiction (e.g., reSET-O, see here , here ).

Documentation 53

Documentation FDA Medication Dispensing Hospitals 53